Cargando…
A Hepatitis B Virus-Derived Peptide Can Inhibit Infection of Human Lung Cells with SARS-CoV-2 in a Type-1 Interferon-Dependent Manner
The current COVID-19 pandemic has highlighted the urgent need to develop effective therapeutic strategies. We evaluated the in vitro antiviral effect against SARS-CoV-2 of a hepatitis B virus (HBV) hexamer peptide, Poly6, which is capable of eliciting an antiviral effect against human immunodeficien...
Autores principales: | Choi, Yu-Min, Jeong, Hyein, Park, Uni, Cho, Nam-Hyuk, Kim, Bum-Joon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310041/ https://www.ncbi.nlm.nih.gov/pubmed/34202029 http://dx.doi.org/10.3390/v13071227 |
Ejemplares similares
-
A Novel DNA Vaccine Against SARS-CoV-2 Encoding a Chimeric Protein of Its Receptor-Binding Domain (RBD) Fused to the Amino-Terminal Region of Hepatitis B Virus preS1 With a W4P Mutation
por: Jeong, Hyein, et al.
Publicado: (2021) -
Inhibition of HIV-1 reactivation by a telomerase-derived peptide in a HSP90-dependent manner
por: Kim, Hong, et al.
Publicado: (2016) -
Bleomycin-Induced Lung Injury Increases Resistance to Influenza Virus Infection in a Type I Interferon-Dependent Manner
por: Seo, Sang-Uk, et al.
Publicado: (2021) -
Enhancing immune protection against MERS-CoV: the synergistic effect of proteolytic cleavage sites and the fusion peptide and RBD domain targeting VLP immunization
por: Oh, Jeein, et al.
Publicado: (2023) -
Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections
por: Kim, Byoung-Jun, et al.
Publicado: (2021)